(ROST) Ross Stores - Overview
Stock: Apparel, Accessories, Footwear, Home-Fashions
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.12% |
| Yield on Cost 5y | 1.42% |
| Yield CAGR 5y | 9.18% |
| Payout Consistency | 93.5% |
| Payout Ratio | 25.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.9% |
| Relative Tail Risk | -12.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.08 |
| Alpha | 18.72 |
| Character TTM | |
|---|---|
| Beta | 0.691 |
| Beta Downside | 0.214 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.08% |
| CAGR/Max DD | 0.94 |
Description: ROST Ross Stores January 28, 2026
Ross Stores, Inc. (NASDAQ:ROST) operates a network of off-price retail locations under the Ross Dress for Less and dd’s DISCOUNTS banners, targeting middle-income and lower-moderate-income U.S. households with apparel, accessories, footwear, and home-fashion merchandise. The company, incorporated in 1957 and headquartered in Dublin, California, positions itself as a value-oriented alternative to traditional department stores.
Key recent metrics (as of Q4 2024): • Fiscal 2023 net sales reached $18.6 billion, a 4.2 % increase YoY, driven primarily by a 5.1 % rise in comparable-store sales despite modest traffic growth. • Operating margin expanded to 7.9 % (up from 7.2 % in FY 2022) as the firm improved inventory turnover to 4.8 times per year, reflecting tighter buying cycles in a high-inflation environment. • Consumer confidence indices for the “lower-income” segment have been trending upward (University of Michigan Survey, March 2024), supporting continued demand for discount apparel, while overall U.S. retail sales growth has slowed to 2.1 % YoY, indicating a more price-sensitive market. These data suggest that Ross’s off-price model remains resilient amid broader retail headwinds, but its performance is still tied to macro-economic variables such as disposable-income trends and inflation expectations.
For a deeper, data-driven assessment of Ross Stores’ valuation dynamics, you may find it worthwhile to explore the analytical tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income: 2.09b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.42 > 1.0 |
| NWC/Revenue: 11.85% < 20% (prev 13.10%; Δ -1.25% < -1%) |
| CFO/TA 0.18 > 3% & CFO 2.79b > Net Income 2.09b |
| Net Debt (1.13b) to EBITDA (3.54b): 0.32 < 3 |
| Current Ratio: 1.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (325.1m) vs 12m ago -1.48% < -2% |
| Gross Margin: 27.55% > 18% (prev 0.28%; Δ 2727 % > 0.5%) |
| Asset Turnover: 145.3% > 50% (prev 142.5%; Δ 2.80% > 0%) |
| Interest Coverage Ratio: 57.35 > 6 (EBITDA TTM 3.54b / Interest Expense TTM 46.7m) |
Altman Z'' 3.74
| A: 0.17 (Total Current Assets 7.63b - Total Current Liabilities 5.02b) / Total Assets 15.41b |
| B: 0.29 (Retained Earnings 4.47b / Total Assets 15.41b) |
| C: 0.18 (EBIT TTM 2.68b / Avg Total Assets 15.16b) |
| D: 0.47 (Book Value of Equity 4.47b / Total Liabilities 9.53b) |
| Altman-Z'' Score: 3.74 = AA |
Beneish M -2.90
| DSRI: 1.12 (Receivables 203.9m/176.2m, Revenue 22.03b/21.24b) |
| GMI: 1.02 (GM 27.55% / 28.00%) |
| AQI: 1.07 (AQ_t 0.02 / AQ_t-1 0.02) |
| SGI: 1.04 (Revenue 22.03b / 21.24b) |
| TATA: -0.05 (NI 2.09b - CFO 2.79b) / TA 15.41b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of ROST shares?
Over the past week, the price has changed by +1.11%, over one month by +1.71%, over three months by +19.31% and over the past year by +32.99%.
Is ROST a buy, sell or hold?
- StrongBuy: 11
- Buy: 4
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ROST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 193.3 | 1.3% |
| Analysts Target Price | 193.3 | 1.3% |
| ValueRay Target Price | 226 | 18.5% |
ROST Fundamental Data Overview February 01, 2026
P/E Forward = 26.5252
P/S = 2.7854
P/B = 10.369
P/EG = 2.7927
Revenue TTM = 22.03b USD
EBIT TTM = 2.68b USD
EBITDA TTM = 3.54b USD
Long Term Debt = 1.02b USD (from longTermDebt, last quarter)
Short Term Debt = 1.22b USD (from shortTermDebt, last quarter)
Debt = 5.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.13b USD (from netDebt column, last quarter)
Enterprise Value = 62.48b USD (61.35b + Debt 5.19b - CCE 4.06b)
Interest Coverage Ratio = 57.35 (Ebit TTM 2.68b / Interest Expense TTM 46.7m)
EV/FCF = 31.82x (Enterprise Value 62.48b / FCF TTM 1.96b)
FCF Yield = 3.14% (FCF TTM 1.96b / Enterprise Value 62.48b)
FCF Margin = 8.91% (FCF TTM 1.96b / Revenue TTM 22.03b)
Net Margin = 9.47% (Net Income TTM 2.09b / Revenue TTM 22.03b)
Gross Margin = 27.55% ((Revenue TTM 22.03b - Cost of Revenue TTM 15.96b) / Revenue TTM)
Gross Margin QoQ = 28.00% (prev 27.62%)
Tobins Q-Ratio = 4.05 (Enterprise Value 62.48b / Total Assets 15.41b)
Interest Expense / Debt = 0.24% (Interest Expense 12.5m / Debt 5.19b)
Taxrate = 24.98% (170.5m / 682.4m)
NOPAT = 2.01b (EBIT 2.68b * (1 - 24.98%))
Current Ratio = 1.52 (Total Current Assets 7.63b / Total Current Liabilities 5.02b)
Debt / Equity = 0.88 (Debt 5.19b / totalStockholderEquity, last quarter 5.88b)
Debt / EBITDA = 0.32 (Net Debt 1.13b / EBITDA 3.54b)
Debt / FCF = 0.57 (Net Debt 1.13b / FCF TTM 1.96b)
Total Stockholder Equity = 5.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.76% (Net Income 2.09b / Total Assets 15.41b)
RoE = 36.75% (Net Income TTM 2.09b / Total Stockholder Equity 5.68b)
RoCE = 40.01% (EBIT 2.68b / Capital Employed (Equity 5.68b + L.T.Debt 1.02b))
RoIC = 27.27% (NOPAT 2.01b / Invested Capital 7.37b)
WACC = 7.81% (E(61.35b)/V(66.54b) * Re(8.46%) + D(5.19b)/V(66.54b) * Rd(0.24%) * (1-Tc(0.25)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.68%
[DCF Debug] Terminal Value 78.21% ; FCFF base≈1.85b ; Y1≈1.78b ; Y5≈1.74b
Fair Price DCF = 95.51 (EV 32.02b - Net Debt 1.13b = Equity 30.89b / Shares 323.4m; r=7.81% [WACC]; 5y FCF grow -5.18% → 2.90% )
EPS Correlation: -2.33 | EPS CAGR: -42.48% | SUE: -4.0 | # QB: 0
Revenue Correlation: 64.75 | Revenue CAGR: 2.96% | SUE: 2.51 | # QB: 1
EPS next Quarter (2026-04-30): EPS=1.61 | Chg30d=+0.012 | Revisions Net=+1 | Analysts=11
EPS next Year (2027-01-31): EPS=7.15 | Chg30d=+0.048 | Revisions Net=+2 | Growth EPS=+10.5% | Growth Revenue=+5.6%